Q32 Bio (QTTB) Operating Expenses (2017 - 2026)

Q32 Bio has reported Operating Expenses for 10 years, with the latest figure at $7.7 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 36.85% year-over-year to $7.7 million; the trailing twelve-month figure through Mar 2026 stood at $32.3 million (down 49.08% YoY), and the FY2025 full-year result was $36.8 million, down 44.28% from the prior year.
• Operating Expenses for Q1 2026 stood at $7.7 million, down from $7.9 million in the prior quarter.
• The five-year high for Operating Expenses was $38.4 million in Q1 2022, with the low at $7.6 million in Q3 2025.
• Average Operating Expenses over 5 years is $17.0 million, with a median of $12.2 million recorded in 2025.
• Year-over-year, Operating Expenses sank 73.14% in 2023 and jumped 94.82% in 2024.
• Tracing QTTB's Operating Expenses over 5 years: stood at $35.3 million in 2022, then plunged by 68.42% to $11.1 million in 2023, then soared by 30.31% to $14.5 million in 2024, then slumped by 45.9% to $7.9 million in 2025, then decreased by 1.73% to $7.7 million in 2026.
• The last three Operating Expenses figures came in at $7.7 million (Q1 2026), $7.9 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.

Peer Comparison